| 1. | | Recruiting | Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes
Conditions: de novo myelodysplastic syndromes; previously treated myelodysplastic syndromes; secondary myelodysplastic syndromes; ... |
| 2. | | Recruiting | CC-5013 in Treating Patients With Transfusion-Dependent Low-Risk or Intermediate-Risk Myelodysplastic Syndrome
Conditions: Chronic Myelomonocytic Leukemia; previously treated myelodysplastic syndromes; de novo myelodysplastic syndromes; ... |
| 3. | | Recruiting | Daclizumab Compared With Antithymocyte Globulin in Treating Cytopenia in Patients With Myelodysplastic Syndromes
Conditions: Refractory Anemia; refractory anemia with ringed sideroblasts; refractory anemia with excess blasts; previously treated myelodysplastic syndromes; ... |
| 4. | | Recruiting | Infliximab in Treating Patients With Myelodysplastic Syndrome
Conditions: refractory anemia with excess blasts; refractory anemia with ringed sideroblasts; Refractory Anemia; de novo myelodysplastic syndromes; ... |
| 5. | | Recruiting | Low-Dose Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Allogeneic Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorder or Myelodysplastic Syndrome
Conditions: Polycythemia Vera; Essential Thrombocythemia; de novo myelodysplastic syndromes; previously treated myelodysplastic syndromes; ... |
| 6. | | Recruiting | Cholecalciferol in Treating Patients With Myelodysplastic Syndrome
Conditions: previously treated myelodysplastic syndromes; de novo myelodysplastic syndromes; secondary myelodysplastic syndromes; ... |
| 7. | | Recruiting | Thalidomide and Epoetin alfa in Treating Anemia in Patients With Myelodysplastic Syndrome
Conditions: de novo myelodysplastic syndromes; secondary myelodysplastic syndromes; previously treated myelodysplastic syndromes; Anemia; ... |
| 8. | | Recruiting | Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia; previously treated myelodysplastic syndromes; secondary myelodysplastic syndromes; de novo myelodysplastic syndromes; ... |
| 9. | | Recruiting | Antithymocyte Globulin and Cyclosporine Compared With Standard Therapy in Treating Patients With Myelodysplastic Syndrome
Conditions: Refractory Anemia; refractory anemia with ringed sideroblasts; refractory anemia with excess blasts; de novo myelodysplastic syndromes; ... |
| 10. | | Recruiting | Darbepoetin alfa in Treating Anemic Patients With Myelodysplastic Syndromes
Conditions: Anemia; Fatigue; Myelodysplastic Syndromes |
| 11. | | Recruiting | Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes
Conditions: Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes |
| 12. | | Recruiting | Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
Conditions: adult acute myeloid leukemia; atypical chronic myeloid leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes; ... |
| 13. | | Recruiting | PKC412 With or Without Itraconazole in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Conditions: adult acute myeloid leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes |
| 14. | | Not yet recruiting | Reduced-Intensity Regimen Before Donor Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndromes
Conditions: atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes |
| 15. | | Recruiting | Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome
Conditions: atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes |
| 16. | | Recruiting | Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome
Conditions: atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes |
| 17. | | Recruiting | Umbilical Cord Blood Transplantation in Treating Patients With Severe Aplastic Anemia, Malignant Thymoma, or Myelodysplasia
Conditions: atypical chronic myeloid leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes |
| 18. | | Recruiting | VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia
Conditions: adult acute myeloid leukemia; atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; ... |
| 19. | | Recruiting | Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome
Conditions: adult acute myeloid leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes |
| 20. | | Recruiting | Tipifarnib in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome in Complete Remission
Conditions: adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes |
| 21. | | Recruiting | Radiolabeled Monoclonal Antibody Therapy Combined With Total-body Irradiation, Allogeneic Peripheral Stem Cell Transplantation, and Immunosuppression Therapy in Treating Older Patients Who Have Advanced Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
Conditions: adult acute myeloid leukemia; atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; Graft Versus Host Disease; ... |
| 22. | | Recruiting | Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic Syndromes
Conditions: Leukemia; Myelodysplastic Syndromes |
| 23. | | Recruiting | Fludarabine, Low-Dose Total-Body Irradiation, Donor Stem Cell Transplantation, and Immunosuppression Therapy in Treating Patients Who Have Fanconi’s Anemia
Conditions: Fanconi's Anemia; adult acute myeloid leukemia; childhood acute myeloid leukemia; Graft Versus Host Disease; Myelodysplastic Syndromes |
| 24. | | Recruiting | Donor Stem Cell Transplantation With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome
Conditions: atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; juvenile myelomonocytic leukemia; myelodysplastic and myeloproliferative disease; ... |
| 25. | | Recruiting | Daunorubicin and Cytarabine With or Without Zosuquidar Trihydrochloride in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia
Conditions: adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; Myelodysplastic Syndromes; secondary acute myeloid leukemia |
| 26. | | Recruiting | Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer
Conditions: adult acute myeloid leukemia; atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; ... |
| 27. | | Recruiting | A Study of Darbepoetin Alfa in Anemic Subjects with Low Risk Myelodysplastic Syndrome
Condition: Myelodysplastic Syndromes |
| 28. | | Recruiting | PKC412 in Patients with Acute Myeloid Leukemia and Patients with Myelodysplastic Syndrome with either Wild Type or Mutated FLT3
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndromes |
| 29. | | Recruiting | Selective T-Cell Depletion to Reduce Graft-Versus-Host-Disease in Patients Receiving Stem Cell Transplantation to Treat Leukemia, Lymphoma or Myelodysplastic Syndromes
Conditions: Graft vs Host Disease; Myelodysplastic Syndromes; Leukemia; Leukemia, Myeloid; Leukemia, Myelomonocytic, chronic; Leukemia, Lymphocytyc; Lymphoma; ... |
| 30. | | Recruiting | Decitabine versus Supportive Care in Adults with Advanced-stage MDS
Condition: Myelodysplastic Syndrome |
| 31. | | Recruiting | Allo Transplantation with Mylotarg, fludarabine and melphalan for AML, CML and MDS.
Conditions: Acute Myelogenous Leukemia; Myelodysplastic Syndrome; Chronic Lymphocytic Leukemia |
| 32. | | Recruiting | Lower-Dose Chemotherapy and Stem Cell Transplantation to Treat Childhood Leukemias and Lymphomas
Conditions: Hodgkin Lymphoma; Lymphocytic Leukemia; Mixed Cell Leukemia; Myelodysplastic Syndrome; Non Hodgkin's Lymphoma |
| 33. | | Recruiting | Clofarabine alone versus Clofarabine in Combination with Low-Dose Cytarabine (ara-C) in Previously Untreated Patients with Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndrome |
| 34. | | Recruiting | Collection of Blood and Bone Marrow from Normal Volunteers and Patients for Research Purposes
Conditions: Aplastic Anemia; Fanconi's Anemia; Healthy; Hematologic Disease; Myelodysplastic Syndrome |
| 35. | | Recruiting | Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
Conditions: adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; Myelodysplastic Syndromes |
| 36. | | Recruiting | Study of AP23573 in Patients with Relapsed or Refractory Hematologic Malignancies
Conditions: Hematologic Malignancies; Leukemia; Myelodysplastic Syndromes; Myeloid Metaplasia; Lymphoma |
| 37. | | Recruiting | A Survival Study in Patients with High Risk Myelodysplastic Syndromes Comparing Azacitidine versus Conventional Care
Condition: Myelodysplastic Syndromes |
| 38. | | Recruiting | Prophylaxis Trial of Posaconazole vs. Standard Azole Therapy for Neutropenic Patients
Conditions: Leukemia, Myelocytic, Acute; Myelodysplastic Syndromes; Neutropenia |
| 39. | | Recruiting | Safety and Efficacy of Hum195/rGel in Patients with Advanced Myeloid Malignancies
Conditions: Myelodysplastic Syndromes; Leukemia, Myelocytic, Acute; Anemia, Refractory, with Excess of Blasts; Myeloproliferative Disorders |
| 40. | | Recruiting | Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
Condition: Myelodysplastic Syndromes |
| 41. | | Recruiting | Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes |
| 42. | | Recruiting | Blood and Marrow Transplant Clinical Research Network
Conditions: Bone Marrow Transplantation; Blood Disease; Hematopoietic Stem Cell Transplantation; Leukemia; Multiple Myeloma; Myelodysplastic Syndromes; ... |
| 43. | | Recruiting | Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
Conditions: recurrent childhood acute myeloid leukemia; secondary acute myeloid leukemia; previously treated myelodysplastic syndromes |
| 44. | | Recruiting | Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 45. | | Recruiting | CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 46. | | Recruiting | OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 47. | | Recruiting | VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 48. | | Recruiting | Combination Chemotherapy and Thalidomide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes
Conditions: adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 49. | | Recruiting | Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia; adult acute monoblastic and acute monocytic leukemia; atypical chronic myeloid leukemia; childhood acute monocytic leukemia; ... |
| 50. | | Recruiting | Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers
Conditions: Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; Myelodysplastic Syndrome |
